Leveraging the interaction of Herceptin with the HER-2 receptor located on the cell membrane, CdSe/ZnS core/shell QDs were coupled with Herceptin to specifically interact with HER2-overexpressing breast carcinoma cells (SK-BR3) and increase apoptosis. Here, ERBB2 is linked to breast carcinoma.